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ABSTRACT 
This thesis explores the zebrafish as a model organism to illuminate our understanding 
of processes that orchestrate the progression of cancer metastasis and myogenesis.  
 
First, I describe the successful establishment of a cancer metastasis model in the 
zebrafish, specifically to study intravasation - one of the earliest steps in the metastatic 
cascade. Fluorescently labeled tumour cell are transplanted into pervitelline space of 2 
days post fertilisation (dpf) zebrafish embryos before they are exposed to normoxic or 
hypoxic conditions, allowing us to study the effect of hypoxia on tumour-induced 
angiogenesis and metastasis. Hypoxia elicited an enhanced angiogenic response and 
neovascularisation to the transplanted tumour and escalated the extent of metastasis in 
the living zebrafish embryo. Loss of function experiments such as vascular endothelial 
growth factor (VEGF) blockade using a clinically available drug – Sunitinib or VEGF 
morpholino knockdown attenuated tumour-induced angiogenesis and metastasis. The in 
vivo metastasis assay in zebrafish delivers numerous unique advantages over 
conventional in vitro cell-based or biochemical chemotaxis assays. The transparent 
embryo facilitates the tracking of the entire intravasation process in real time within a 
living organism, allowing us to explore the dynamic interplay of tumour cells and the 
environmental cues that drive metastasis. This model can be further employed to 
discriminate between tumour cells of different metastatic potential and to identify novel 
factors that present as impetus for the earliest step of the metastatic cascade. 
 
Next, I demonstrate the analysis of one class of motility mutants originally identified in 
the 1996 Tübingen genetic screen that potentially serve as models for human 
myopathies and dystrophies. Two of these mutants have previously been cloned and 
shown to encode proteins involved in muscle fibre attachment whilst a third has been 
found to encode the molecular chaperone Heat shock protein (HSP) 90. I describe the 
phenotypic and molecular characterization of another of these zebrafish motility 
mutants, frozen (fro). I present evidence that the frot027c mutation disrupts the locus 
encoding the autophagy pathway component Atg10. This analysis implicates Atg10 in 
the assembly of both skeletal and cardiac muscle fibers suggesting a previously 
uncharacterized role for the autophagy pathway in this process.  
 
Together, my findings illustrate the utility of the zebrafish as a model organism that 
complements established mammalian and invertebrate models. The fecundity and 
amenability of the zebrafish to genetic manipulation together with the rapid 
development and translucency of its embryos combine to provide a powerful system 
with which to unravel and inform the underlying mechanisms that govern fundamental 
biological processes and shed light on our understanding of human development and 
diseases. 
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INTRODUCTION 
 
1.1 WHY FISH? 
1.1.1 What is a zebrafish?! 
 
  
 
 
 
 
 
 
 
 
“What is a zebrafish?!” friends will probe with amused frowns when I explained that I 
am performing zebrafish research for my PhD. Yes, the first image that dawned upon 
many may be a hybrid of a zebra and a fish (Figure 1). Freaking scary?!? Fortunately, 
this is not the case!  
 
 
 
 
 
 
 
 
 
The zebrafish (Danio rerio) is a tropical freshwater species named for the five 
horizontal pigmented stripes that run longitudinally across their bodies (Figure 2). 
Belonging to the minnow family of Cyprinidae and derived from the genus Danio, they 
originate from the Ganges river in India. The zebrafish used to be known only as 
ubiquitous inhabitants of home aquariums until Dr. George Streisinger from the 
University of Oregon adopted this species as an ideal vertebrate in which to perform 
genetic analysis of behaviour in the late 1960s. Ever since, zebrafish has become a 
popular animal model for developmental biology studies, especially for investigating 
mechanisms that orchestrate generation of different germ layers [3], organogenesis [4], 
locomotion [5], formation of different brain circuits [6] and establishment of vascular 
architecture [7] (Figure 3). Several illuminating advantages of the zebrafish propelled 
its popularity to be utilised as the model organism in over 600 laboratories worldwide 
today. First and foremeost, zebrfish are small (growing up to 4 cm in captivity) and 
Figure 1. Hybrid of a zebra and a fish. [1].  
Figure 2. Zebrafish. The zebrafish are tropical freshwater teleosts that are found in northern India, 
southern Pakistan, Nepal and Bhutan in south Asia. [2] 
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easy to maintain in large numbers in inexpensive aquariums. They are easy to handle 
during experimentation, requiring minimally invasive procedures and technically 
simple manipulations such as microinjection. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Timeline of landmarks in zebrafish research. [8]. 
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1.1.2 Significant numbers 
Problems that many scientist are burdened with when using mouse as animal models 
include long generation time (2-3 months to reach sexual maturity, each female 
produces 5-10 litter per year) and limited number of embryos for analysis (each litter 
will generate at most 6-8 pups). Additionally, mouse embryos develop in utero and 
analysis of embryos requires dissection and sacrificing of pregnant females to allow 
examination of the pups. Zebrafish on the other hand produce hundreds of eggs in one 
clutch and more importantly, their embryos develop ex utero. This means that females 
do not need to be exposed to invasive manipulation and the entirety of the 
developmental process from a fertilized egg to a swimming larva can be observed in a 
petri dish!  
 
The large numbers of embryos garnered from each mating and their rapid development 
(heart, vessels and nervous systems are functional within 2-4 days) empower 
researchers the ability to expedite genetic analysis within a shorter time.  
 
1.1.3 The power of Seeing-Through 
Zebrafish embryos are transparent, providing scientists an opportunity to follow the fate 
of individual cells throughout development as well as to observe processes such as cell 
migration in real time in vivo simply on a dissecting microscope. This is unattainable in 
other model systems. Research work by Judith Eisen, Brant Weinstein and Leonard 
Zon’s laboratories have demonstrated that with the generation of transgenic lines in 
these see-through embryos, the zebrafish is an unparallel model for studying neuronal 
growth [9] and vascular development [10].  
 
The transparent zebrafish is therefore amendable to optogenetics – using optical-
sensitve technology to photoactivate proteins, one application of which is to track cell 
fate in an intact biological organism. The Kaede is a green fluorescent protein (GPF)-
like protein that undergoes a permanent green to red conversion upon UV exposure. 
Transparency of zebrafish embryos merged with photo-convertibility of Kaede has 
catapulted neural circuitry studies into a new level. For example, neuronal 
subpopulations can be visualized in real time and extended fate mapping can be 
performed [11-13]. 
 
1.1.4 Genetic Operators 
An impressive repertoire of genetic tools such as chemically and transposon induced 
mutations, binary misexpression systems, antisense morpholino oligonucleotide 
mediated gene knockdown and zinc finger nuclease mediated targeted mutangenesis, 
are available to manipulate the zebrafish genome, making it the pre-eminent small 
animal model for functional genomic studies. Forward genetics using unbiased N-ethyl-
N-nitrosourea (ENU) mutagenesis screens permitted the isolating of defective 
phenotype in mutants, facilitating the rapid identification of novel genes essential for 
development. 
 
Elegant experiments such as cell transplantation can be performed to investigate if the 
gene of interest functions autonomously or non-autonomously by transplanting mutant 
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donor cells into wildtype host embryos and vice versa [14]. Chimera embryos created 
by transplanting donor cells to targeted host tissues will allow us to investigate how 
donor cells respond to and influence the host environment, providing insights to 
numerous questions in developmental biology.  
 
Maternal contribution is frequently required for early embryonic patterning and to a 
degree compensate for the loss of zygotic gene function [15, 16]. In zebrafish, maternal 
zygotic mutants can be created by replacing the endogenous primordial germ cell 
(PGC) with germ cells derived from homozygous mutant donors, therefore developing 
an excellent tool for unfolding the maternal effects of zygotic lethal mutations.   
 
1.1.5 Have you validated your findings in a vertebrate? 
 
Yes, in case you don’t know, zebrafish have backbones and are therefore vertebrates! 
This means that zebrafish are more closely related to humans than Drosophila and 
Caenorhabditis elegans (which are invertebrates).  
 
“The lineages of teleost fish and mammals separated about 500 million years ago, and 
although fish and people do not look the same, they have many common physiological 
systems and anatomical features.” – Sydney Brenner, False starts [17] 
 
Many important developmental processes are highly conserved between teleosts and 
human, therefore zebrafish provides a platform for comparative embryological and 
evolution studies. John Postlethwait’s group for instance has used the zebrafish to 
perform comparative genomics to unveil evolutionary diversification and to investigate 
the link between conserved non-coding elements and genome contraction and 
expansion [18].  Teleosts undergo an additional third round of whole-genome 
duplication (WGD) compared to other vertebrates which go through only two rounds of 
WGD.  The subsequent extra round of WGD that occurred in the zebrafish about 320-
400 million years ago [19] is advantageous as it is possible to conduct comparative 
genomics analysis between mammals and teleosts. Mammals including human contain 
four clusters of Hox genes which are clusters of genes important for determining basic 
structure and orientation of an organism[20]. Teleosts such as the zebrafish have seven 
clusters of Hox genes - approximately twice that of mammals possibly due to the 
additional round of WGD [21-24]. The identification of sub-functionalisation of 
duplicated genes will inform us about genome evolution and more importantly, 
recognize clusters of genes that are from the same lineage and present information on 
their predicted functions in mammals.  
 
A robust vertebrate that is transparent, develops rapidly, closely related to humans and 
is highly amenable for genetic manipulation, the zebrafish is an amazing model 
organism to bridge the missing gaps between mammalian and invertebrate models.  
 
1.2 HOW TO SEE VESSELS IN THE ZEBRAFISH? 
1.2.1 Vasculogenesis & angiogenesis in zebrafish 
Vasculogenesis entails the recruitment of circulating endothelial cells differentiated 
from stem cells (angioblasts) into newly formed blood vessels [25]. The endothelial 
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cell lattice created by vasculogenesis serves as a scaffold for angiogenesis. The heart 
is the first organ that is functional in the zebrafish embryo, consisting of two 
chambers - one atrium and one ventricle - separated by an atrioventricular valve. 
Angioblasts in the intermediate cell mass (ICM) that are destined for blood vessel 
development express several transcription factors such as gata-2, fli1, lmo2 and scl. 
[26, 27]. Vasculature development in zebrafish embryos occurs in two waves. The 
primary wave of vasculogenesis occurs by 12 hours post fertilisation (hpf) when the 
vascular cord starts to form by intracellular and intercellular vacuoles fusion. The 
dorsal aorta (DA) and the posterior cardinal vein (PCV) will be evident by 24 hpf and 
arterial sprouts will start emanating from the DA and sprout dorsally following the 
boundaries of the somites. Angiogenesis ensues as sprouting tip cells will extend and 
retract their filapodia to explore all directions for cues for directional migration. As 
early as 30 hpf, intersegmental vessels (ISV) will be developed [28]. The robust 
patterning of the ISV has singled it out as one of the most studied vessels in the 
zebrafish embryo. Several morphogenic mechanisms have been proposed for the 
lumenization of the ISV such as budding [29] or cord hallowing [30, 31]. Secondary 
wave of sprouting emerges from the PCV and specifies the venous fate. Only primary 
vascular sprouts that are not attacked by the secondary vein-derived cells will retain 
their arterial fate. Ephrin-B2 marks the arterial cells while Eph-B4 and flt4 are 
predominantly expressed in the venous endothelial cells [32, 33].  
 
Numerous studies in the zebrafish have uncovered the molecular control of vessel 
development which involves Hedgehog (Hh), vascular endothelial growth factor 
(VEGF) and Notch signaling [34-37]. Hh signalling has been implicated in vascular 
tube formation in the mouse embryo and for vascular cord formation in cultured mouse 
endothelial cells [38] as well as in zebrafish. Hh signaling emanating from the 
notochord stimulates VEGF expression in the somites which further activate Notch 
signaling to specify arterial fate. There are 4 Notch receptors (1-4). Specifically, Notch 
1 and 4 are expressed in the endothelial cells together with their ligands such as Delta-
like 1 (Dll1), Delta-like 4 (Dll4), Jagged-1 (Jag1), and Jagged-2 (Jag2). Downstream 
targets of Notch signaling include Hes-related proteins (Hey/HRT/HERP) [39]. As well 
as acting indirectly in arterial differentiation through its regulation of VEGF, Hh 
signaling may also function directly to specific arterial fate as Patched 1 (the 
downstream receptor of Hh ligand) is expressed in endothelial cells. This suggests that 
the molecular dissection of arterial differentiation in zebrafish warrant further studies.  
 
The ease of in vivo analysis, genetic tractability and amenability to drug administration, 
makes the zebrafish an excellent model system to dissect molecular mechanisms that 
orchestrate angiogenesis and metastasis. Furthermore, the availability of transgenic 
flk1:EGFP and fli1:EGFP zebrafish lines, in  which the endothelial cells are labelled by 
GFP (Figure 4), allows tracking of neovessel growth with single vessel resolution in 
real time using a fluorescent dissecting microscope.  
 
1.2.2 Monitoring metastasis 
A benign tumour is a mass of high proliferative index cancer cells that are growing 
rapidly. At this stage the tumours are usually small and therefore attain their supply of 
nutrients and oxygen via simple diffusion. However, when the tumour reaches a critical 
mass of 1-2 mm in diameter, the inner core undergoes necrosis and further expansion of 
the tumour cell population demands higher supply of nutrition to sustain its rapid 
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growth. Within the confines of a tumour, the availability of nutrients is limited by 
competition among actively proliferating cells, and diffusion of metabolites is impeded 
by high interstitial pressure [40]. As a result, tumour cells induce the formation of a 
new blood supply from the preexisting vasculature, and this offers tumour cells the 
ability to survive and propagate in a hostile environment [41] by producing multiple 
growth factors that individually or synergistically stimulate vessel growth. This 
constitutes the process of pathologically-induced angiogenesis. Similarly, growth of 
lymphatic vessels into the primary tumour may be induced by angiogenic factors to 
further support growth of the aggressive cancerous cells [42]. Intravasation occurs 
when tumour cells protrude through the basement membrane of endothelial cells of 
blood or lymphatic vessels and invade the hematogenic or lymphatic circulation. 
Within the circulation, tumour cells may be disseminated to many different organs, 
including the liver, lungs and brain. Nonetheless, a large proportion of tumour cells will 
die in such foreign and harsh environment while those that have acquired a higher 
selective advantage through additional mutations will survive. Upon encountering a 
favourable environment, these aggressive tumour cells will dislodge into the organ 
(extravasation) and home onto a secondary site which is distal from the primary 
tumour, resulting in the process of metastasis (Figure 5). Metastatic spread of cancer 
indicates that the tumour is malignant and in most cases treatment is usually difficult. 
At such an advanced stage, palliative treatment is usually given to alleviate patient’s 
suffering. Other therapies such as hormonal therapy, chemotherapy and radiation are 
given in conjunction only whenever they are deemed suitable. The “soil and seed 
hypothesis”, coined by Stephen Paget as long ago as 1889, suggested that a dynamic 
interaction between the tumour (seed) and microenvironment (soil) is important for 
sustained survival and growth of the tumour [43].   
 
To understand mechanisms that govern the metastatic cascade, several classical animal 
assays have been developed. Orthotopic (tissue of origin) transplantation of tumours 
into mice to initiate primary tumour growth and subsequent metastasis is used to study 
the metastatic process. This spontaneous assay method is time-consuming, laborious 
and results in poor quantification statistically [44]. Injection of tumour cells directly 
into the circulation via the tail vein in mouse has frequently been employed to 
investigate steps that facilitate organ selectivity for secondary tumour growth. One 
disadvantage of this method is that it only uncovers mechanisms that govern that last 
step of the metastatic cascade – extravasation and not intravasation.  
 
In this thesis, I will present the zebrafish as a model to assay the intravasation process 
of metastasis. Dissection and elucidation of dynamic interactions of the metastatic 
cascade will uncover key targets and overcome barriers to clinical development that 
will ultimately lead to better patient outcome. 
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Figure 4. Vasculature of Tg(flk1:EGFP) zebrafish at 48 hpf. MsV – Mesencephalic vein; PCeV – 
Posterior cerebral vein; BA – Basilar artery; DLAL – Dorsal longitudinal anastomotic vessel; Se – 
Intersegmental vesel; CA – Caudal artery; CV – Caudal vein; DA – Dorsal aorta; PCV – Posterior 
cardinal vein; H – Heart; IOC – Inner optic circle. (unpublished data) 
 
Figure 5. Major steps of the metastatic cascade. (a) Growth of neoplastic cells constitutes the primary 
tumour. (b) Induction of angiogenesis occurs when tumour growth exceeds 1-2mm in diameter. (c) 
Intravasation began when local invasion of tumour cells into the stromal tissue and subsequent attack of 
the lymphatics or blood circulation is initiated. (d) Many tumour cells are destroyed upon entering the 
circulation. Tumours cells that survive may arrest in capillary beds of a favourable microenvironment in a 
distal organ. (e) Extravasation occurs when tumour cells home onto a secondary site. (f) The 
establishment of a secondary tumour away from the primary tumour site signals the spread of the cancer 
– metastasis. Growth of blood vessels will be induced to further support the proliferation of these 
micrometastatic tumours. [45] 
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Figure 6. Atg12 and Atg8 conjugation system in autophagosome formation. [46] 
 
 
Figure 7. Steps of autophagy. (a) Induction of nucleation. (b) Phagophore formation and vesicle membrane 
expansion. (c) Autophagosome formation. (d) Autophagosome-lysosome fusion. (e) Degradation of cytosolic 
components. Cover from [47] and schematic diagram from [48]  
Table 1. Table depicting phenotypes of tissue-specific knockout mice of ATG-related genes. F, floxed 
allele; MLC2v, myosin light chain 2v; Mlc1, myosin light chain 1; HAS, human skeletal actin; EL, 
elastase I; Rip, rat insulin promoter. [49] 
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1.2.3 Cancer metastasis model in fish  
The transparent zebrafish embryo offers unique opportunities for elucidating 
tumourigenic processes such as metastasis and angiogenesis that are refractory to 
analysis in mammalian tumour models. The spontaneous metastasis assay and tail-vein 
metastasis models in mouse suffer from numerous drawbacks such as poor 
reproducibility, sensitivity to oxygen tension and poor quantification. One of the many 
attractions of the zebrafish metastasis model is that the progression of a large number of 
easily observable tumour grafts can be monitored in the optically transparent living 
zebrafish in vivo by utilizing high-resolution confocal imaging. Furthermore with the 
availability of transgenic flk1:EGFP and fli1:EGFP zebrafish embryos, with their 
endothelial cells highlighted, tracking of metastasising cells up to single cell resolution 
has become possible.  
 
The zebrafish metastasis model presents a number of promising advantages including 
ease of animal maintenance and experimentation, short assay time; accurate 
quantitation and amenability to genetic analysis. A number of examples of zebrafish 
xenograft have recently appeared in the literature, supporting the view that it is a 
powerful model for understanding human cancer progression such as angiogenesis and 
metastasis [50].  
 
Xenotransplanting of metastatic melanoma WM-266-4 cells, colorectal cancer SW620 
cells and pancreatic cancer FG CAS/Crk cells into hindbrain ventricles of 2 dpf 
zebrafish embryos supports proliferation, migration, melanin production and cell mass 
aggregation of these cell lines [51]. Using immunohistochemistry analysis, these 
authors also show that these xenografts stimulate angiogenesis in zebrafish.  
 
Another group illustrated that implantation of human endometrial adenocarcinoma 
cells, human ovarian carcinoma A2780 cells, human breast carcinoma MDA-MB-435 
cells or murine melanoma B16-BL16 cells into the perivitelline space of 48 hpf 
zebrafish embryos induced neovascularisation at 72 hpf [52]. Using transgenic 
VEGFR2:G-RCFP zebrafish embryos to highlight the newly formed vasculature, they 
also demonstrated that microinjection of cells that overexpress angiogenic factors such 
as FGF2 (Fibroblast growth factor 2) into the perivitelline cavity elicits 
neovascularisation from the developing sub-intestinal vessels. More importantly, the 
same group demonstrated that systematic exposure of the zebrafish xenografts to 
angiogenic inhibitors such as FGF receptor tyrosine kinase inhibitor SU5402 and 
VEGFR2/KDR tyrosine kinase inhibitor SU5416 antagonizes neovessel growth 
without compromising normal vessel development. Antisense morpholino 
oligonucleotide knockdown of vascular endothelial cadherin (VE-cadherin), an 
important cell adhesion gene that marks the inter-endothelial cell junction, suppressed 
tumour-induced angiogenesis. With its well-defined vasculature observed with 
profound optical clarity within GFP-expressing transgenic fish, the above study 
illustrated that zebrafish is an ideal model for an intact whole animal in vivo 
angiogenesis assay. Additionally, targeted knock down via antisense morpholino 
 10 
oligonucleotides and dominant negative inhibition technology available in the zebrafish 
integrated with its superior imaging qualities offer it as the premier animal to dissect 
mechanisms that orchestrate tumour-induced angiogenesis and metastasis.  
 
The recent burgeoning literature on zebrafish xenograft models has given us additional 
insights into how the zebrafish has become a promising in vivo intact model for 
elucidating angiogenesis processes that are unreached by analysis in other mammalian 
tumour models. It has been demonstrated that the zebrafish xenograft model displays 
striking similarity in discriminating between highly angiogenic and poorly angiogenic 
tumour cell lines when compared to the chick chorioallantoic membrane assay and 
mouse corneal angiogenesis assay [53].  
 
Findings presented in this thesis will illustrate the potential of the zebrafish metastasis 
model, not only for drug discovery and gene targeting in tumour-induced metastasis but 
also as an attractive tool for unravelling the many conundrums in tumour biology, cell 
biology and even tumour immunology.  
 
1.3 FISH MYOGENESIS 
1.3.1 Muscle development in the zebrafish 
 
Skeletal muscles empower locomotion and maintain posture, constituting 42% and 
36% of the body mass in males and females respectively [54]. A large proportion of the 
zebrafish body is made up of skeletal muscles (80%), therefore offering it as an 
attractive vertebrate model to study myogenesis as their muscle fibers are highly 
accessible for analysis. Muscle fibres are further classified into slow and fast twitch 
muscles. Slow twitch muscles (Type I) appear red in colour as it is interweaved with 
blood vessels and undergo oxidative respiration to provide energy for maintenance of 
normal body functions such as breathing and walking. Fast twitch muscles (Type II) 
appear white as it is devoid of vasculature and is utilized for burst of activities such as 
the fight and flight response via non-oxidative respiration.  Muscle fibres are composed 
of bundles of myofibrils which comprises of tandem arrays of sarcomeres – alternating 
thin and thick myofilaments that form the basic contractile unit of a muscle. The 
assembly of a sarcomeric unit is a complicated process involving the interdigitation of 
actin and myosin myofilaments into highly ordered bundles. Precisely how sarcomeres 
are assembled remains a mystery, although several models have been proposed.  
 
Studies in live chick cardiomyocytes have suggested that premyofibrils initially form at 
the spreading edge near the cell membrane and act as temporary scaffolds for mature 
myofibril assembly. Αlpha-actinin-rich Z bodies in the premyofibrils fused to form 
mature Z-bands constituting the Z lines (Zwischenscheibe-lines), giving skeletal muscle 
its striated appearance [55]. An alternative model is that the thin and thick filaments 
first form independently before interdigitating to assemble mature myofibrils [56, 57]. 
Other studies have demonstrated that titin and integrin are essential for the assembly of 
a highly ordered sarcomeric structures [58-60]. It has also been suggested that calcium 
influx plays an essential role in the organization and maintenance of sarcomere 
structures [61]. In the absence of troponin in the developing zebrafish, there is a loss of 
sarcomeric structures due to a lack of thin filament composition and deregulated of 
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actin-myosin activity [62]. Several lines of evidence indicated that protein quality 
control via protein turnover and degradation is critical for maintaining myofibril 
integrity [63]. 
 
In the zebrafish, slow-twitch muscle fibres are superficially located while fast-twitch 
muscle fibres are medially located. Somites originate from the paraxial mesoderm 
during gastrulation and by 8-10 somite stage, expression of MyoD and Myf5 (basic 
helix-loop-helix transcription factors) will drive myogenesis. Hh signaling emanating 
from the notochord functions in a dose-dependent manner to specify slow cell fate in 
the zebrafish myotome [64, 65]. Slow muscles migrates to the superficial surface and 
majority of the medial skeletal muscle in the zebrafish is made up of fast-twitch muscle 
fibres [66]. Hh activates the Prdm1 (ubo gene) in zebrafish embryos, activating slow-
twitch fibre differentiation and inhibiting fast-fibre-specific genes, as well as 
attenuating the repression of slow-fibre-specific genes, therefore specifying the slow-
twitch fate [67-73]. Emerging evidence indicates that microRNAs (miRNAs) which are 
small non-coding RNA may mediate Hh activity for determining slow-twitch muscle 
fibre fate. miRNA-214 attenuates Su(fu) levels – a negative regulator of Hh signaling – 
and therefore leading to a subtle increase in slow-twitch fate muscle fibres [74]. By 24 
hpf, somites will adopt its chevron shape. Dorsal and ventral somites are separated by 
the horizontal myoseptum and neighbouring somites are divided vertically by the 
vertical myoseptum.  
 
The ideal platform for investigating the emergent progression of embryonic muscle 
formation in the teleost is an in vivo model to trace how the plethora of sarcomeric 
proteins dynamically assembles into a functional myotome. The combination of well-
defined muscle architecture of the zebrafish together with its unprecedented system for 
examining genes in vivo, the zebrafish have become an emerging and promising model 
for understanding development of the myotome. 
 
1.3.2 My fish cannot swim – Immotility mutants 
Forward genetic analysis offers a powerful approach to dissecting complex biological 
processes. Mutagenesis is induced in the zebrafish via several methods such as ENU 
(chemical mutagenesis), radiation or gamma rays or retroviruses insertions [75]. The 
incredible fecundity of zebrafish [76] expedites genetic mapping and identification of  
mutations has been made rapid and easy.  
 
Screens by Nobel Prize-winning Christiane Nüsslein-Volhard identified numerous 
mutants that display immotility phenotypes in zebrafish. Phenotypic studies using 
birefringency assay identified 18 genes that have a role in muscle development. frozen 
(fro), sloth (slo) and fibrils unbundled (fub) are three mutants that are classified under 
the group of immotility mutants which have reduced or no muscle striations. Their 
offspring are totally paralyzed and unresponsive to tactile stimuli. The sapje mutant 
also isolated from this 1996 large-scale screen was later shown to be defective in the 
dystrophin gene, disrupting embryonic muscle attachments and resulting in its 
progressive muscle degeneration phenotype [77-79]. Interestingly, mutations in the 
same locus in humans causes Duchene and Becker muscular dystrophies in patients, 
thus offering sapje mutant as an ideal for modeling human myopathies and for drug 
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screening to fish out potential drug targets [80]. These findings illustrated that 
forward genetic screens has offers us an enticing possibility of uncovering novel 
genes in disease mechanisms by employing sophisticated genetic manipulation in the 
zebrafish.  
 
 
1.3.3 “Eating oneself” – Autophagy 
“But while the famous cannibal dined on chunks of his enemies and friends, most 
people stick to gnawing on themselves at a microscopic level. In fact, the cells of 
organisms from yeast to humans regularly engage in self-cannibalism. Cells chew on 
bits of their cytoplasm — the jellylike substance that fills their bellies — and dine on 
their own internal organs” - [47] 
 
Imagine that there is a tiny Hannibal Lecter in the cells among all of us. This may be a 
macabre thought but in fact, the process of munching on one’s own contents is 
important for every cell to manage stress and for survival. Autophagy 
(macroautophagy) is a process by which superfluous cytosolic proteins such as 
macromolecules (abnormal protein aggregates) and organelles (mitochondria) are 
removed and recycled by the lysosomal degradation pathway. Autophagy can be 
classified into three different types – autophagy (targeting cytoplasmic components to 
lysosome via autophagosome), microautophagy (invagination of lysosomal membrane 
to engulf cytosolic contents) and chaperone-mediated autophagy (translocation directly 
to the lysosome via the recognition of a specific peptide sequence). Since Christian de 
Duve first coined the term “autophagy” in 1967, this process has been shown to be 
essential for many mechanisms such as cellular adaptation and survival during 
metabolic stress and nutrient deprivation [81-83], neurodegenerative protection for 
Parkinson’s disease [84-86], Huntington’s disease [87-89], degradation of intracellular 
pathogens and viruses in infectious diseases [90-93], protection against muscle diseases 
such as sporadiac inclusion body myositis, limb girdle muscular dystrophy type 2B and 
miyoshi myopathies [94, 95]. More interestingly, increasing evidence has suggested 
autophagy to be a double-edged sword in cancer progression – governing tumour 
suppression by mediating the Atg6 - Becilin [96] or promoting oncogenesis by 
supporting survival of metabolically-stressed tumour cells [97, 98].  
 
Autophagy is a complex process consisting of a cascade of steps - induction, cargo 
packing and selectivity, vesicle nucleation, autophagosome formation, vesicle fusion 
with lysosome and autophagosome breakdown – each step employing a specific subset 
of autophagy-related genes (Atg) genes [99]. A repertoire of 32 Atgs is first discovered 
in budding yeast - Saccharomyces cerevisiae by genetic screens [48, 100]. Atg genes 
are highly conserved among all species as it is a fundamentally important process for 
controlling protein turnover. Atg13, Atg6 and phosphatidylinositol (PtdIns) 3-kinase 
complex is essential for induction and nucleation of the phagophore membrane, 
swallowing up superfluous and abnormal components such as protein aggregates and 
enlarged mitochondria. Yeast and mammalian studies revealed that Bcl-2 (an anti-
apoptotic protein) inhibits Becilin -1 (atg6), stalling the nucleation step and inhibiting 
autophagy [101]. Upon successful nucleation, two conjugation systems are activated. 
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Firstly, the Atg12-Atg5-Atg16 complex is assembled and this process is facilitated by 
E1 ubiquitin activating enzyme and E2 ubiquitin conjugating enzyme - Atg7 and Atg10 
respectively. Subsequently, formation of a second conjugate - Atg8- 
phosphatidylethanolamine (PE) is promoted by both Atg7 and Atg3, thereby advancing 
the autophagome expansion step (Figure 6). Fusion of the autophagosome with the 
lysosome will initiate the degradation of the cargo by acidic hydrolyases (Figure 7).  
 
Defects in the autophagic pathway have been shown to lead to several myopathies 
including Danon disease and Pompe disease. Danon disease patients carry mutations in 
lysosomal-associated membrane protein 2 (LAMP-2), which cause a failure of 
autophagosome-lysosome fusion and a consequent accumulation of autophagic 
vacuoles containing cytoplasmic debris or sarcoplasmic membranes [102]. The 
vacuoles are most prominent in skeletal muscle and ultimately lead to myofibre 
splitting and degeneration. Danon patients also commonly suffer from hypertrophic 
cardiomyopathy [103, 104]. Deficiency of glycogen-degrading lysosomal enzyme acid 
α-glucosidase (GAA) causes Pompe disease, usually characterised by an accumulation 
of glycogen in the lysosomes due to a reduction in the autophagic clearance [105]. The 
contractile force of the muscle becomes compromised as the disease progresses. 
Interestingly, chronic administration of chloroquine – a commonly used anti-malaria 
drug has been shown to inhibit autophagy, resulting in vacuolar myopathies in both rats 
and humans that are characterised by the appearance of rimmed vacuoles in the muscle 
fibres [106].  
 
1.3.4 Autophagy in muscle development 
Numerous tissue specific mouse knockouts have been generated to elucidate the 
function of autophagy in erythrocyte, lymphocyte and adipocyte differentiation (Table 
1).  
 
In addition, two Atg tissue specific knockout mouse have been produced to study the 
role of autophagy in both skeletal and cardiac muscles. Targeted ablation of Atg7 in 
mouse skeletal muscle leads to atrophy, reduction in muscle mass and age-dependent 
decrease in muscle contraction force as well as the accumulation of p62 [107] whereas 
specific cardiac muscle knockout of Atg5 results in cardiac hypertrophy, left ventricle 
dilation and systolic dysfunction [108]. Both Atg5-/- and Atg7-/- mice suffer from 
neonatal lethality with reduced amino acids levels. It has also been demonstrated that 
attenuation of autophagy in cardiomyocytes in vitro can lead to dramatically enhanced 
aggresome accumulation upon excessive cardiac stress and pressure overload [109, 
110]. Suppression of autophagy in skeletal muscles of healthy wildtype mouse also 
increased aggregation of autophagic substrates, such as p67 and polyubiquitinated 
proteins [111-113].  Armed with the numerous genetic tools previoulsy described, it is 
enticing to use zebrafish as a model organism to elucidate further the role of autophagy 
in muscle development.  
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2 AIMS 
The objective of this thesis is to use the transparent zebrafish embryo to uncover some 
of the molecular and cellular mechanisms underlying the metastatic cascade as well as 
muscle fibre differentiation.  
 
To achieve these aims, I have conducted two distinct sets of studies:  
 
• Establishment of an in vivo metastasis model using the zebrafish embryo 
(Studies I and II) 
 
• Investigate the role of Atg10 in myofibrillogenesis in a motility zebrafish 
mutant – frozen (Study III) 
 
The ultimate significance of these studies is to hopefully one day: 
 
• Identify subgroup of human tumour cells that are of different metastatic 
potential using the zebrafish metastasis model. This will lead to better 
prognosis and treatment of cancer patients. 
 
•  Decipher the interplay of Atg10 and muscle fibre assembly during early 
development and unveil steps that maybe implicated in muscular myopathies.  
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MATERIALS AND METHODS 
Important parameters and limiting factors of key methods to investigate tumour 
metastasis and myogenesis in the zebrafish will be explained and discussed in this 
section.  
 
2.1 IN VITRO LABELING OF TUMOUR CELLS 
Prior to injection, tumour cells were gown in Dulbecco’s Modified Eagle Medium 
(DMEM, Gibco Biocult) supplemented with 10% fetal calf serum (FCS), 1% 
streptomycin and 1% penicillin until approximately 70-80% confluence. The adherent 
tumour cells were labeled in vitro with 2 µg/ml of 1,1´-Dioctadecyl-3,3,3´,3´-
tetramethylindocarbocyanine perchlorate (DiI, Fluka, Germany) for 45 minutes to 60 
minutes at 37°C. DiI is a hydrophobic and lipophilic dye that labels cell membranes, 
therefore labeling the entire tumour cells fluorescent. Instead of labeling adherent 
cultured cells, suspended cells can also be labeled successfully with DiI. It is important 
to note that cell suspension of higher density such as > 1 x 107 cells / ml would require 
longer incubation period for uniform staining of cells. Different cells types require 
varying incubation periods. Optimal staining by DiI cell-labeling solution for different 
cell type and densities can be quantified by flow cytometry.  
 
DiI was washed away and the labeled cells were rinsed thoroughly three times with 
PBS, re-plated and incubated for another 24 hours. The tumour cells were checked for 
ubiquitous and uniform labeling under a fluorescence stereo-miscrocope prior to 
implantation.  
 
2.2 ZEBRAFISH TUMOUR METASTASIS MODEL 
To study the role of mechanisms in promoting early events of the metastatic cascade in 
relation to angiogenesis, we developed a zebrafish tumour model in which the 
Tg(fli1:EGFP) zebrafish embryos were implanted with mouse or human tumours cells. 
24 hpf fish embryos were incubated with water containing 0.2 mM 1-phenyl-2-thio-
urea (Sigma) to prevent pigmentation. At 48 hpf, zebrafish embryos of the 
Tg(fli1:EGFP) strain were dechorionated with help of a sharp tip forceps and 
anesthetized with 0.04 mg/ml of tricaine (MS-222, Sigma). Anesthetized embryos were 
transferred onto a modified agarose gel for microinjection. DiI-labeled murine T241 
tumour cells are injected into the perivitelline cavity of 48 hpf-old embryos. 
Approximately 100-500 DiI-labeled tumour cells were resuspended in serum-free 
DMEM medium (Sigma) and 5 nl of tumour cell solution were injected into the 
perivitelline cavity of each embryo using an Eppendorf microinjector (FemtoJet 5247 
and Inject Man NI2 microinjection apparatus, Eppendorf, Hamburg Germany). Non-
filamentous borosilicate glass capillaries needles were used for the microinjection (1.0 
mm in diameter, World Presicion Instruments, Inc. USA). Note that filamentous 
needles which are utilised for morpholino injections should not be used for 
transplantation of tumour cells as the filament in the needles will cause sheering of the 
tumour cells upon injection. Diameter of the non-filamentous needles should be just 
small enough for single cell transplantation and not too large as this will result in 
creating a wound in the zebrafish embryos that will cause the transplanted tumour cells 
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to leak out instead. Wide diameter needles are also unwieldy and bulky for tumour 
transplantation.  
 
After injection, embryos were immediately transferred into embryo E3-water. Injected 
embryos were kept at 28°C and were examined every other day for monitoring tumour 
growth and invasion using a fluorescent microscope (Nikon Eclipse C1, Japan). 
Mastering of this tumour transplantation technique in zebrafish entails focused 
attention, perseverance and calm spirit.  
 
Some may argue that cell lines are unable to survive within the zebrafish embryos 
because established standard incubation temperature of cell lines is 37 °C while in 
sharp contrast, zebrafish normally require water temperature ranging from 25 °C to 28 
°C [114]. Extremely high temperature will lower the oxygen content of the water and 
will not be healthy for the survival of zebrafish embryos. However, it has been 
demonstrated that mammalian cells within the zebrafish continue to undergo mitosis 
and presented no signs of apoptosis during incubation at 28 °C [53]. It has been 
speculated that aggressive human metastatic melanoma cells transplanted into blastula 
stage zebrafish embryos retained the ability to metastasize to vascular areas [115]. It 
has been demonstrated that BrdU is incorporated into the newly synthesized DNA in 
the human melanoma cell nuclei, indicating that these tumours retain their proliferative 
potential. Moreover, one group showed that elevation of the incubation temperature to 
35 °C did not affect the morphology of various organs such as the heart, liver, pancreas 
and intestine as these vital organs did not display aberrant differences from those 
zebrafish incubated at 28 °C [51]. Altogether, these suggest that the zebrafish embryos 
corroborate the survival of human metastatic melanoma cells and these melanoma cells 
proliferate and migrate probably by responding to surrounding microenviromental cues. 
 
Besides performing xenograft implantation in zebrafish embryos, recently, one group 
has also microinjected human tumour cells into juvenile zebrafish. Utilising the 
transgenic fli1:EGFP zebrafish which has green fluorescent-labeled vasculature, they 
showed that microinjection of human adenocarcinoma MDA-MB-435 (MDA-435), 
fibrosarcoma (HT1080) and melanoma (B16) cells into the peritoneal cavity of 
chemically immunosuppressed 1 month old zebrafish leads to formation of microscopic 
tumours, angiogenesis and intravsation of tumour cells into the vessel [116]. They used 
their zebrafish xenograft model to investigate whether the human metastatic gene - 
RhoC and VEGFC work synergistically to promote the initial steps of metastasis by 
engineering MDA-RhoC cells that secrete human VEGF and implanting these cells into 
one month old zebrafish. These authors demonstrated that that MDA-435 cells which 
expressed both RhoC and VEGF formed larger membrane protrusions extending into 
the vessels in comparison to controls, suggesting that RhoC and VEGFC worked 
cooperatively to mediate cancer cell intravasation. Zebrafish injected with PBS or 10 
µm fluorescent beads did not have any angiogenic or metastatic response, suggesting 
that the angiogenic response elicited by the tumour cells is indeed caused by tumour-
induced angiogenesis and not by wound-induced angiogenesis.  
 
Using juvenile fish as a canvas for studying cancer and blood vessel interaction closely 
recapitulates tumour-induced remodeling of the vasculature in cancer patients. Another 
advantage of using embryos over the juvenile zebrafish is that embryos have immature 
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immunity, therefore no graft rejection occurs upon xenograft implantation [53]. 
Moreover, it is important to note that using dexamethasone chemically 
immunosuppressed 1 month old zebrafish may not be ideal for assaying angiogenic 
response as it has been reported that dexamethasone inhibits angiogenesis [117] [118] 
[119] [120], this may render the angiogenesis assay insensitive and underestimate the 
therapeutic significance of some potential drugs.  
 
2.3 WHOLE MOUNT ZEBRAFISH IMMUNOFLUORESCENCE 
Immunohistochemistry was performed as previously described [67]. Embryos were 
fixed in 4% PFA. Primary antibodies such as mouse monoclonal anti α-Actinin 
(1:1000, Sigma) and mouse monoclonal anti-light meromyosin (1:500, DSHB) were 
used. Anti-mouse secondary antibodies Alexa 546 (Molecular Probe) were used at a 
dilution of 1:2000. 4',6-diamidino-2-phenylindole, dihydrochloride, DAPI (1:2000, 
Molecular Probe) was used to stain the nuclei. Phalloidin Tetramethylrhodamine B 
isothiocynate (Sigma) prepared in 2.5 μg/μl stock was used for actin staining at a 
dilution of 1:300. It is of importance to note that phalloidin-actin staining does not work 
on methanol-treated embryos. Likewise, phalloidin powder should be dissolved in 
dimethyl sulfoxide (DMSO) instead of methanol. All embryos should be fixed and 
stored in phosphate buffered saline (PBS) at 4 °C prior to phalloidin staining. Imaging 
was performed using a Zeiss LSM 510 confocal microscope.  
 
2.4 WESTERN BLOT ON ZEBRAFISH LYSATE 
Whole embryos lysate were resolved by sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE), transferred onto Immobilon-P Polyvinylidene Fluoride 
(PVDF) membranes and immunoblotted with specific primary and secondary 
antibodies conjugated to alkaline phosphatase. Good negative and positive controls 
should be prepared to test for the specificity of the antibodies. mRNA overexpression in 
wildtype embryos will produce a band of the desired molecular weight at a higher 
intensity. While ATG start morpholino or splice morpholino knockdown in wildtype 
embryos will produce either no band or a weaker band at the same molecular weight. 
Such controls are essential to validate the specificity of the antibodies used on whole 
embryo lysate. 
 
2.5 LIVE IMAGING USING CONFOCAL MICROSCOPE 
Live embryos were anesthetised with 0.16 mg/ml tricaine (Sigma, A5040) and 
immersed in 1% low melting agarose gel (Agarose type IX-A, Sigma) on depression 
slides and observed using a Leica MZ16F stereo-microscope (Germany). To image 
embryos at a specific lateral surface, zebrafish should be orientated to the desired 
position immediately upon embedding them in warm low melting agarose. Placing 
these embedded embryos on ice for 5 minutes will expedite the solidification of the 
low-melting agarose. A drop of water is placed on the low melting agarose before 
imaging the embryos under a 40x water immersion lens. High-resolution images were 
taken using an Olympus FV1000 upright confocal microscope (Japan). Three-
dimensional images were assembled and reconstructed using the FV10-ASW software 
(Olympus, Japan) and processed using Photoshop software (Adobe). 
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3 RESULTS AND CONCLUSIONS 
3.1 THE ZEBRAFISH METASTASIS MODEL (STUDIES I & II) 
Mechanisms that orchestrate pathological angiogenesis in relation to hypoxia in tumour 
invasion and metastasis remain elusive. To date, there is no evidence of an ideal animal 
model to investigate tumour cell dissemination and metastasis in an entire living 
organism in real time.  
 
We have developed a zebrafish tumour model that allows us to study the role of 
tumour-induced angiogenesis under normoxia and hypoxia in arbitrating early events of 
the metastatic cascade at the single cell resolution. Under normoxia, implantation of a 
murine T241 fibrosarcoma into the perivitelline cavity of developing embryos of 
transgenic fli1:EGFP zebrafish did not result in significant dissemination, invasion and 
metastasis. In sharp contrast, significant numbers of tumour cells disseminated from 
primary sites, invaded into neighboring tissues, and metastasized to distal parts of the 
fish body under hypoxic conditions. Similarly, overexpression of the hypoxia-regulated 
angiogenic factor - vascular endothelial growth factor (VEGF) resulted in tumour cell 
dissemination and metastasis, which is well-correlated with increased tumour 
neovascularization.  
 
Inhibition of VEGF receptor signaling pathways by sunitinib or VEGFR2 morpholinos 
abrogated the VEGF-induced tumour cell dissemination and metastasis. Utilizing the 
transparency of the zebrafish embryo, we demonstrate hypoxia- and VEGF-induced 
pathological angiogenesis in promoting tumour dissemination, invasion, and metastasis 
at the single cell level. These findings further provide compelling evidence on the 
beneficial effects of clinically available anti-VEGF drugs for cancer therapy. 
 
3.2 ATG-10 IN MYOGENESIS (STUDY III) 
Autophagy (macroautophagy) is a self-cannabilisation process, which breakdowns 
long-lived organelles and superfluous harmful misfolded proteins by directing them to 
the lysosomes for degradation, thereby recycling cellular components to maintain 
homeostasis and biogenesis within the living cell.   
 
Through the characterization of the zebrafish, frozen (fro) mutant identified in the 1996 
Tübingen genetic screen as one of a group of immotile mutants [5], a novel role for 
autophagy in the assembly of myofibrils within muscle fibres has been uncovered. fro 
mutants are easily identified at 48 hpf as they display a significant reduction in 
birefringency under polarized light, indicative of a defect in myotome patterning, 
muscle fibre disorganization or muscle volume loss. Meiotic mapping localized fro to a 
genomic interval across which a BAC tiling path was assembled. Injection of individual 
BACS into mutant embryos identified one BAC, zC219M24, can rescue the mutant 
phenotype. This BAC contains three transcription units, zgc:123341 - Atg10, ssbp2 and 
tmem167a.  
 
Injection of Atg10 mRNA and cDNA rescued the sarcomeric structure of muscle fibres 
in fro embryos. Injection of morpholino antisense oligonucleotides targeting Atg10 
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phenocopied fro, confirming atg10 as the causative locus. Detailed analysis of fro 
mutants using electron microscopy and mitochondria-specific dyes revealed an 
accumulation of enlarged mitochondria, indicative of a defect in autophagic clearance 
within the myocytes. In addition, accumulation of large cellular vacuoles, which is 
morphologically strikingly similar to human vacuolar myopathies, is clearly evident in 
fro. Defects in the autophagic pathway are known to lead to several human myopathies 
including Danon disease and Pompe disease. Further analysis of this and other 
autophagy gene mutations in zebrafish will elucidate possible mechanisms for muscular 
degenerative diseases and human myopathies and hopefully, lead to better therapeutic 
interventions for patients suffering from these debilitating diseases.  
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4 DISCUSSION 
4.1 WHY VESSELS AND MUSCLES? 
My initial motivation to study the mechanisms that govern growth of blood vessels into 
tumours came from my fascination with the unraveling of teratogenic effects of 
Thalidomide: this drug that caused devastating malformalities in newborns such as 
amelia, was found to act by inhibiting integrin leading to abrogation of angiogenesis. 
Knowledge of the mechanism of action of thalidomide led to its subsequent use as an 
anti-angiogenic drug for treatment of cancer patients. Amazed by the optical clarity 
provided by the zebrafish, I proposed to several potential supervisors to study 
angiogenesis in the zebrafish. More importantly, it dawned upon me that to circumvent 
a disease, you must first decipher its mode of action and understand at which stage 
something has gone awry. Philip Ingham cordially accepted my idea of transplanting 
tumour cells into zebrafish. Mastering the transplantation technique, experimenting 
with numerous dyes to stain tumour cells and being amazed by how fluorescent tumour 
cells spread in the transparent zebrafish embryos constituted my first year of PhD work 
in his lab. Further developing this technique in the Karolinska Institutet, I described 
how tumour cells metastasized in the zebrafish under hypoxic conditions.  
 
Understanding the cellular and molecular basis of vessel maturation and how 
metastasis occur is central to delineating the full “life cycle” of blood vessels and lays 
the foundation for developing effective pro-angiogenic and anti-angiogenic therapies. 
On an important note, discovering how and which signals initiate the metastatic 
cascade may create a plethora of novel therapeutic targets. Evidence such as 
abrogation of the extent of metastasis by VEGF blockade through impairment of 
tumour-induced angiogenesis in our zebrafish metastasis model has spawned a first 
glimpse of this therapeutic potential.  
 
Two years later during a discussion with Phil at the EMBO Conference in Amsterdam, 
he described the frozen mutant phenotype to me and the intriguing finding that it 
appeared to disrupt a gene involved in the autophagy pathway. Given the rich expertise 
in Phil’s lab in studying muscle development and fascinated by cachexia – a kind of 
muscle wasting syndrome in cancer patients and enthralled by the implication of 
autophagy in tumour progression, I was compelled to seize this opportunity and delve 
into understanding the characterization of this interesting mutation. Intrigued by a 
documentary which illustrated a young teenager who is diagnosed with muscular 
dystrophy and how this chronic debilitating disease is slowly rotting away every bit of 
his muscle, I sought to understand what went wrong in the muscle of this mutant 
zebrafish.  
 
 
4.2 DETECTING THE NEEDLE IN A HAYSTACK 
When patients are officially diagnosed with cancer after numerous diagnostic tests, 
usually it is not surprising that these cancers are classified as stage 4 cancer. Stage 4 
cancer defines that the tumour is malignant and metastasis has already occurred. In 
2011 alone, the American Cancer Society’s statistics estimated that 571,950 cancer 
deaths is expected to occur and approximately 1.5 million new cancer cases are 
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expected to be diagnosed [121]. With the advances in today’s technology, I am 
astounded to realize that there is a lack of sensitive imaging machines to detect 
cancerous cells earlier. Why are cancerous cells so hard to detect? Why is it that a 
primary tumour cannot be first detected before patients are severely riddled with 
micrometastasis? One explanation is that these cancerous tumour cells evolve and 
undergo numerous changes in their genetic make-up, therefore acquiring selective 
advantage over other cells - similar to Darwin’s theory of “survival of the fittest” – the 
theory that supported how finches and tortoises survived on the Galapagos’ island. 
Eventually only the most aggressive tumour cells continue to overproliferate. Constant 
accumulation of multiple mutations such as activation of membrane transporters that 
pump out chemotherapeutic drugs, evasion of the immune detection and promotion of 
blood vessel growth offer these tumour cells a competitive advantage over other cells, 
rendering chemotherapy treatment challenging and ineffective in patient outcome. 
Additionally, tumours are not composed of only one type of cell, they are 
heterogeneous – made up of mosaic cells that are actively acquiring new mutations for 
survival. Combination treatment using numerous chemotherapeutic drugs may not 
target and exterminate all cells within the tumour, usually the most resistant and 
aggressive cells will evade these treatments and continue to proliferate. Only in cases 
when the cancer is localized, surgery and radiation will be considerably effective. 
 
To combat this “incurable” disease, there are many questions that warrant further study. 
Which part of the metastatic cascade is most amendable to clinical intervention? 
Obviously, targeting the intravasation process rather than the extravasation step will 
theoretically engender better patient outcome as attenuating the very first step of the 
metastasis cascade before tumour cells invaded the circulation will be the most 
important step to intervene to abrogate the spread of these aggressive cells. So what are 
the genomic signature or biomarkers for different kind of cancers before they 
intravasate into the circulation?  Which subset of tumour cells do we target for different 
kinds of cancer?  Given the plethora of different tumours such as breast, lung, ovarian, 
pancreatic and lung cancers, it seems challenging to scour for good biomarkers for each 
cancer patient group. Recently five promising candidate markers ascertain for 
identifying females with ovarian cancers in early studies fell short of expectation after 
vigorous testing [122, 123]. Likewise, OvaSure - a diagnostic kit selling a panel of six 
biomarkers which claim to aid early detection in ovarian cancer was pulled out from the 
market by the US Food and Drug administration (FDA) after erroneous statistics were 
found in earlier studies which falsely over exemplify the significance of these markers 
in ovarian cancer detection. Similarly, “breakthrough” biomarkers for early detection of 
breast and prostate cancers also engender false positive results and failed to go through 
clinical trials. Evidently, rigorous statistical tests have to be done on potential 
biomarkers on larger independent groups to deliver better reliable results. Lessons from 
previous failed biomarkers also suggest that potential biomarkers should be carefully 
validated before expensive clinical trials are conducted.  
 
Why do some tumours relapse with vengeance? A mass of tumour cells that have 
acquired a balance between proliferation and cell death resulting in no net increase in 
tumour volume constitutes dormant tumour cells. Mechanisms supporting tumour 
dormancy remains elusive to date. Latency period is defined as the time of first 
treatment and recurrence of the tumour – reflecting relapse of cancer. Mesothelioma 
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and breast cancers are intractable in nature owing particularly to their long latency 
period [124-126]. Disseminated tumour cells have been detected in breast cancer 
patient up to 22 years after successful treatment [127], suggesting that dormant tumour 
cells can be switched on after very long latency, this can create a lot of uncertainty in 
patients. Are dormant tumour cells good therapeutic targets? Impetus for re-awakening 
of dormancy remains largely unknown. Initiation of quiescent dormant cells to active 
regrowth maybe due to sudden activation of the angiogenic switch, elevation of growth 
stimulating factors emanating from the microenvironment or weakening of the 
immunological status of patients. Other external factors such as diet, surgery and 
unforeseen tissue injury may also reactivate dormant disseminated tumour cells [128, 
129]. Though disseminated dormant tumour cells are valid candidates for therapy, 
without a clear understanding of dormancy biology, specifically targeting dormant 
tumour cells prove to be challenging. Here, our zebrafish metastasis model can help to 
understand the genetic signature of the disseminated tumour cells and unravel why 
some tumour cells choose to specifically home in some organs.  
 
"If you can shrink the tumour 50% or more for 28 days you have got the FDA's 
definition of an active drug.” --- Ralph Moss 
 
Numerous studies use tumour size and volume reduction as measurements to be 
directly translated to better patient outcome, but this may not be the case! A toxic drug 
that specifically exterminate tumour cells and shrink tumour volume in a short 
treatment period may bring along with it several harmful non-specific side effects, 
overall resulting in doing more harm than benefit to cancer patients. Therefore, overall 
benefit of any drug should not be based on its ability to shrink tumour volume but 
should be cautiously validated in the context of benefit versus risk to the patient 
outcome, thereby prolonging patient survival. 
 
Despite millions of dollars pumped into cancer research, there is still a paucity of good 
reliable biomarkers, disappointing clinical trial outcomes and lack of understanding of 
tumour dormancy. Discovering the perfect cure for cancer proved to be challenging like 
finding a needle in a haystack. Nonetheless, with novel imaging techniques that can 
detect small dormant glimmers homing in distal organs, harvesting of tumour cells in 
circulation and investigating genomic signature of metastatic biopsies should allow 
better validation of putative biological markers.  
 
 
4.3 FISHING FOR SCIENCE - FOR THE BETTER GOOD OF MANKIND 
“the fish is a frog… is a chicken… is a mouse. It did not matter which animal you chose 
— fundamental processes were fundamentally conserved.” [8]. 
 
As numerous important mechanisms are highly conserved between zebrafish and 
human, it is tantalizing to use zebrafish as a model organism to discover novel genes in 
several human diseases such as neuronal, musculoskeletal, cardiovascular, 
inflammation diseases and even cancer and obesity.  
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Besides the above mentioned diseases and sapje mutants which are previously 
described as a model to study human muscular dystrophies, more recently in Nature 
News, zebrafish became the first fish model for human depression. This “depressed” 
zebrafish carry a mutation in the glucocorticoid receptor (GR) and when left in 
isolation in a tank, it stops swimming and hides at the bottom of the tank – an 
indication of its disability to cope with stress. Glucocorticoids bind to GR and lack of 
glucocorticoids secretion is known to be associated with the inability to deal with 
stress. Fear for example is shown to stimulate increase glucocorticoid secretion – an 
important human cognitive function in order to handle stressful situation. In this fish, 
there is little or no GR activity and bathing them in anti-depressant drugs such as 
fluoxetine (Prozac), a selective serotonin reuptake inhibitor (SSRI) rescued their 
defective behaviour [130].  
 
Other significant advantages of the zebrafish is its tiny size and optical clarity, 
providing it as a unique promising in vivo organism for large scale drug screening over 
conventional cell based in vitro assays.  
 
“Small molecules can be invaluable tools for studying and treating diseases, but 
discovering novel small molecules is a difficult and risky process. Many of the 
challenges of small molecule discovery stem from the inability of in vitro assays to 
model the complex physiology of disease. Consequently, the in vitro assays used in 
small molecule discovery are poor predictors of the beneficial and adverse effects of 
the small molecule when translated to an in vivo setting. We are circumventing these 
problems by performing high throughput small molecule discovery in vivo using 
zebrafish as a model organism.”- Randall Peterson 
 
The tiny size of zebrafish means that drugs only need to be added in minuscule 
quantities into 96-well plates, allowing screening of candidate drugs to be conducted in 
a cost-effective manner. Additionally, drug screening done in an in vivo living system 
will provide insights into the benefits of lead drugs as well as its potential drawbacks of 
non-specific side effective on other non-target organs. One group in Harvard 
demonstrated that high-throughput behavioral profiling in zebrafish identified 
promising new psychotropic drugs and these findings can further elucidate 
pharmacological actions of a myriad of drugs and their targets [131]. For examples, 
they found that a subset of non-steroid anti-inflammatory drugs (NSAIDs) stimulates 
waking in daytime and having lesser effect during night, suggesting that NSAIDs have 
a role in determining daytime activity in addition to inducing sleep during infections 
[132].   
 
Likewise, the sheer potential of the zebrafish metastasis model poses many important 
questions about the molecular basis and clinical relevance of this model to human 
tumourigenesis. How should the results from the zebrafish metastasis assay be 
quantitated and scrutinized to engender reliable and reproducible information? Are 
mechanisms deployed by the zebrafish to induce angiogenesis same as those in 
mammals and humans? Do the leaky angiogenic neovessels in the zebrafish display 
similar vascular markers to those in humans? These are challenging key issues that 
should be resolved before the results from the zebrafish metastasis assay can be 
translated to potential clinical relevance to humans.  
 24 
 
The establishment of the zebrafish metastasis assay will illuminate our understanding 
of how tumour cells intravasate into the circulation by responding to 
microenvironmental cues. Furthermore with the invention of transgenic lines such as 
neutrophil reporter zebrafish - MPO (myeloperoxidase):GFP, investigating tumour 
immunology using the zebrafish metastasis model will be easily achievable in the near 
future. 
 
To me, the humble zebrafish has definitely earned its stripes! 
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 ABSTRACT 
This thesis explores the zebrafish as a model organism to illuminate our understanding of 
processes that orchestrate the progression of cancer metastasis and myogenesis.  
 
First, I describe the successful establishment of a cancer metastasis model in the 
zebrafish, specifically to study intravasation - one of the earliest steps in the metastatic 
cascade. Fluorescently labeled tumour cell are transplanted into pervitelline space of 2 
days post fertilisation (dpf) zebrafish embryos before they are exposed to normoxic or 
hypoxic conditions, allowing us to study the effect of hypoxia on tumour-induced 
angiogenesis and metastasis. Hypoxia elicited an enhanced angiogenic response and 
neovascularisation to the transplanted tumour and escalated the extent of metastasis in the 
living zebrafish embryo. Loss of function experiments such as vascular endothelial 
growth factor (VEGF) blockade using a clinically available drug – Sunitinib or VEGF 
morpholino knockdown attenuated tumour-induced angiogenesis and metastasis. The in 
vivo metastasis assay in zebrafish delivers numerous unique advantages over conventional 
in vitro cell-based or biochemical chemotaxis assays. The transparent embryo facilitates 
the tracking of the entire intravasation process in real time within a living organism, 
allowing us to explore the dynamic interplay of tumour cells and the environmental cues 
that drive metastasis. This model can be further employed to discriminate between tumour 
cells of different metastatic potential and to identify novel factors that present as impetus 
for the earliest step of the metastatic cascade. 
 
Next, I demonstrate the analysis of one class of motility mutants originally identified in 
the 1996 Tübingen genetic screen that potentially serve as models for human myopathies 
and dystrophies. Two of these mutants have previously been cloned and shown to encode 
proteins involved in muscle fibre attachment whilst a third has been found to encode the 
molecular chaperone Heat shock protein (HSP) 90. I describe the phenotypic and 
molecular characterization of another of these zebrafish motility mutants, frozen (fro). I 
present evidence that the frot027c mutation disrupts the locus encoding the autophagy 
pathway component Atg10. This analysis implicates Atg10 in the assembly of both 
skeletal and cardiac muscle fibers suggesting a previously uncharacterized role for the 
autophagy pathway in this process.  
 
Together, my findings illustrate the utility of the zebrafish as a model organism that 
complements established mammalian and invertebrate models. The fecundity and 
amenability of the zebrafish to genetic manipulation together with the rapid development 
and translucency of its embryos combine to provide a powerful system with which to 
unravel and inform the underlying mechanisms that govern fundamental biological 
processes and shed light on our understanding of human development and diseases. 
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